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1. Introduction 
A part of the N-terminal cryptic region of pro- 
opiomelanocortin (POMC) from bovine intermediate 
lobe pituitary shares the common sequence, Hi-Phe- 
Arg-Trp, with (Y- and @-melanotropin (MSH) and was 
therefore named T-MSH [I]. Since this fragment is 
located between pairs of basic amino acids at Argws7- 
Lysws6 and Arg43-Arg42 or Lys-28-Arg-27, it has 
been suggested [l] that POMC may be enzymatically 
processed in vivo at these basic amino acid pairs to 
yield y-MSH-like peptides in analogy with the biosyn- 
theses of several peptide hormones [2-41. To detect 
y-MSH-like peptides, radioimmunoassays (RIA) for 
the possible fragments, yr-MSH (Tyr-“-Val-Met- 
Gly-His-Phe-Arg-Trp-Asp-Arg-Phe4’-NH,) 
[5], y2-MSH (Tyr-55-Val-Met-Gly-His-Phe-Arg- 
Trp-Asp-Phe-Gly-) [5] and y3-MSH (Tyr-“- 
Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe- 
Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly- 
Val-Gly-Gly-Ala-Ala-Gln-2g) [6,7] were devel- 
oped. The presence of y-MSH-like peptides in extracts 
from a human pituitary adenoma [S] and from anterior 
and intermediate lobes of bovine pituitary [5,9] has 
been reported. We have now completed the isolation 
and structural characterization of a native bovine yr- 
MSH-like peptide. The primary structure of the iso- 
lated yr-MSH was established as H-Lys-Tyr-Val- 
Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH,. 
The amino acid sequence of this peptide corresponds 
to that of the fragment from LYS-~~ to Phe4’ of 
POMC from bovine pituitary; this -/r-MSH is probably 
another naturally occuring peptide arising from specif- 
ic enzymatic processing of POMC in the intermediate 
lobe of the bovine pituitary. 
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2. Materials and methods 
For peptide isolation 42 bovine pituitaries were 
obtained in a local abattoir within 1 O-30 min after 
death. The neurointermediate lobes were immediately 
dissected and frozen in liquid nitrogen. The tissue 
(11.5 g) was extracted by homogenization in 230 ml 
of a mixture of 5% (v/v) formic acid, 1% (v/v) trifluoro- 
acetic acid, 1% (w/v) NaCl in 1 M HCl [lo] first in a 
small blender for 2 min and then in a Polytron homog- 
enizer for 1 min. The homogenate was centrifuged 
(3600 rev&in, 30 min) and the pellet re-extracted 
with 50 ml of the same solvent and centrifuged again. 
The supernatants from the two centrifugations were 
combined and adjusted to pH 2.4 with 5 M NaOH. 
Lipid material was removed from the solution by 
extraction with petroleum ether (twice with equal 
volumes). After degassing with a water aspirator for 
removal of residual organic solvent the defatted extract 
was subjected to reverse-phase peptide extraction as 
in [ 11,121. Briefly, the peptide containing solution 
was pumped through a 20 X 2.5 cm column ffiled 
with octadecasilyl-silica (ODS; LRP-2,37-60 pm 
particle size, Whatman, Clifton NJ). The column was 
then washed free of salt with 0.2 M acetic acid. The 
peptide material retained on the ODS column was 
eluted with 0.36 M pyridine formate (pH 3.0) in 60% 
(v/v)n-propanol and lyophilized (yield: 173 mg). This 
crude peptide fraction was subjected to two steps of 
reverse-phase high-performance liquid chromatography 
(RPLC) on an Altex Model 332 gradient liquid chro- 
matograph (Berkeley CA) using Ultrasphere Cl 8 col- 
umns (5 pm particle size, Altex) in conjunction with 
a mobile phase consisting of 0.36 M pyridine formate 
(pH 3) and a n-propanol gradient [ 131. Column eluates 
were monitored with the fluorescamine stream-sam- 
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pling detection system [ 141 which diverted 2-5% of 
the effluent for detection. Aliquots of chromatography 
fractions were subjected to y-MSH RIA using an anti- 
body which recognizes the antigenic determinant 
-Hi-Phe-Arg-Trp-Asp-Arg-Phe-NH2 [ 51. 
Amino acid analysis was performed on a Liquimat 
III amino acid analyzer (Kontron, Ziirich) equipped 
with an o-phthalaldehyde fluorescence detection sys- 
tem and a proline conversion accessory [ 151. Peptide 
(So-100 pmol) was hydrolyzed and analyzed as in 
[ 161. N-Terminal amino acids were determined with 
lmnol peptide by the dansyl method [ 171. Sequence 
determination was done by automatic Edman degra- 
dation on the Beckman 890 C sequencer using the 
procedures in [ 181. For tryptic peptide mapping the 
peptide was digested with 0.1 pg trypsin (TPCK-treated) 
in 50 ~1 of 2% (w/v) ammonium bicarbonate (pH S), 
containing 8% (v/v) n-propanol (to prevent peptide 
adsorption to polypropylene surfaces). 
3. Results 
The isolation of pure y,-MSH was achieved in 4 
purification steps including tissue extraction, defatting, 
reverse-phase peptide extraction and RPLC. After the 
first RPLC step (fig.1 A) two broad zones containing 
y,-MSH-like immunoreactive material were obtained. 
The first zone contained several relatively well defined 
peaks, aliquots of which were used for amino acid 
analysis. From the fraction identified with an asterisk 
(fig.lA) an amino acid analysis was obtained which 
matched closely that of the POMC fragment Lyses6- 
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg- 
PheA5 (not shown). Rechromatography of this frac- 
tion yielded 40 nmol pure y,-MSH (fig.1 B). 
The amino acid composition of the peptide was 
found to be AsxO.92, Glyl.01, Va10.97, Metl.19, 
Tyrl.04y Phe2.00, fisl.OO, Lysl.OS, TrP0.90~ Arg2.08 
(means from 5 determinations, corrected for blank 
contamination). N-Terminal amino acid analysis 
revealed the presence of lysine and also indicated a 
high degree of purity of the isolated material. Sequence 
analysis with 8 nmol showed the peptide sequence as 
Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp- 
Arg-Phe. (Identification of all phenylthiohydantoin 
amino acids by RPLC was unequivocal except for the 
C-terminal phenylalanine residue.) Because the anti- 
serum that we used recognizes only the amidated syn- 
thetic y,-MSH and crossreacts negligibly with a syn- 
thetic analog having the free carboxyl group at the 
phenylalanine C-terminus the native material is prob- 
ably amidated. Further evidence in support of an 
amidated C-terminal residue was obtained by subject- 
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Fig.1. Final purification of rl-MSH by RPLC. (A) RPLC of 50 mg peptide extract on a semi-preparative RP-18 column (250 X 
10 mm). The sample was dissolved in 10 ml 0.2 M acetic acid and loaded by pumping it directly onto the column. The flow rate 
was 0.8 ml/min and fractions of 2.4 ml were collected. (B) Rechromatography of the fraction marked with an asterisk (A) on an 
analytical RP-18 column (250 X 4.6 mm). For loading the fraction was diluted to 5 ml with 0.2 M acetic acid and injected via a 
5 ml sample injection loop. The flow rate was 0.6 ml/min and 3 min fractions were collected. 
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Fig.2. RPLC of a tryptic digest of 5 nmol purified rl-MSH 
peptide cm an Ultrasphere RI’-18 column (250 X 4.6 mm) in 
the 0.36 M pyridine formate (pti 3)/n-propanol mobile phase. 
For loading the peptide digest was diluted to 0.5 ml with 
0.2 M acetic acid and injected via a 0.5 ml sample loop. The 
flow rate was 0.6 ml/mm. Fractions of 1.8 ml were collected 
and aliquots of peak fractions subjected to ammo acid anal- 
ysis. Arrows indicate retention times of synthetic standards. 
ing the native peptide to tryptic digestion and resolving 
the fragments by RPLC (fig.2). Amino acid analysis 
of the major peaks showed that one of the early eluting 
peaks contained only phenylalanine and therefore 
co~esponded to the C-terminal fragment of 7,-MSH. 
Aliquots of the phenylalanine containing fraction 
were rechromatographed in the same HPLC system 
with and without the presence of exogenous phenyl- 
alanine and phenylalanine amide standards. The iso- 
lated fragment coeluted with phenylalanine amide 
(not shown). 
4. Discussion 
There is considerable knowledge regarding the The isolation of this yi-MSH-like peptide was based 
enzymatic processing of the corticotropin~~-~potropin on a novel approach [ 1 O-1 21 which will be detailed 
portion of POMC in the bovine intermediate lobe elsewhere. Briefly, the goal of the new approach is to 
pituitary [4]. However, not much is known with regard eliminate all procedures which are inefficient (such as 
to the processing of the N-terminal cryptic region of classical c~omatography on soft gels) and, further- 
this precursor. 7i-MSH isolated here is a fragment from more, may lead to loss of material. instead, reverse- 
this cryptic region. The 7,-MSH sequence is located phase peptide extraction and RPLC are the principal 
between 2 pairs of consecutive basic amino acid res- tec~ques employed in the isolation. Reverse-phase 
idues at Arg-57-Lys-56 and Arg43-Arg42. Such peptide extraction is suitable for the rapid prepara- 
double basic sequence regions are potentially important tion of a crude, but highly enriched peptide fraction 
points for enzymatic cleavage of precursor proteins to 
yield mature peptide hormones, such as insulin [2], 
parathyroid hormone [ 31 and corticotropin or @endor- 
phin [4]. However, our data do not permit us to say 
definitely that this 7i-MSH is generated in vivo by 
enzymatic processing of the precursor protein because 
we did not perform pulse-chase xperiments to deter- 
mine the precursor/product relationship. Nevertheless, 
we favor the view that this 7r-MSH arises from intrinsic 
enzymatic processing of POMC, because 7~-MSH-l~e 
immunoreactivity (15OOMr by gel fdtration) was 
found to be released into cell culture medium from 
dispersed intermediate lobe cells of bovine pituitary 
(not shown). Interestingly, the structure of the iso- 
lated yi-MSH has lysine at the N-terminus suggesting 
that POMC can be processed by cleavage between the 
two basic residues Arg-‘? and LYS-~~. This finding is 
in contrast with evidence of a 7-MSH-like peptide 
with N-terminal tyrosine and the third residue being 
methionine [18]. Processing at the C-terminus of yr- 
MSH is strikingly similar to that of cu-MSH. In both 
peptides cleavage is before a characteristic sequence 
Gly-($:>-($) and both peptides have an amidated 
C-terminus. It remains to be established whether such 
a cleavage pattern is due to a specific enzymatic pro- 
cess which would produce peptides with an amidated 
C-terminus that are present in many biologically active 
peptides in nature. Our data also indicate that more 
than one yi-MSH-like peptide exists in the intermedi- 
ate lobe of the bovine pituitary (see e.g., fig.lA, which 
indicates the presence of a 7i-MSH-like immunoreac- 
tive fraction elating prior to the characterized yl- 
MSH). We do not know the structure of the addi- 
tional yi-MSH-like peptide( Further processing of 
the protein precursor after cleavage between the double 
basic sequence Arg-57-Lys-56 and removal of the N- 
terminal lysine might occur and thus yield des-Lysl- 
7,.MSH similar to the yi-MSH-like peptide in [8]. In 
addition, as with cu-MSH [ 191 acetylated forms of 
yi-MSH may be present. 
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and serves for quick transition from large volumes/ 
masses of the original tissue extract to amounts which 
can be subjected directly to RPLC. Also typical in this 
approach is that RPLC is used immediately for the 
separation of complex mixtures rather than for the 
i%-ntl purification of already highly purified materials 
as has frequently been done. Overall peptide recovery 
with our new procedure is high (>90%) making it suit- 
able for ~croisolation as illustrated in our isolation 
of yl-MSH which yielded 2.4 nmol or-MSH/l bovine 
pituitary fragment. The whole isolation procedure 
was completed in 3 days (immunoassays excluded). 
This approach to peptide isolation should enable one 
to isolate other peptides from this or other tissues 
with equal facility. 
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